We are live on
!
Find out more
PP
PDT Partners Portfolio holdings
AUM
$1.69B
1-Year Est. Return
74.01%
This Fund
S&P 500
This Quarter
Est. Return
+6.28%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.31B
AUM Growth
-$78.9M
(-5.7%)
Cap. Flow
-$105M
Cap. Flow
% of AUM
-7.96%
Top 10 Holdings %
Top 10 Hldgs %
6.88%
Holding
1,081
New
330
Increased
200
Reduced
286
Closed
229
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALLK
Allakos
ALLK
|
+$7.87M |
| 2 |
UiPath
PATH
|
+$6.99M |
| 3 |
Marqeta
MQ
|
+$6.41M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$5.72M |
| 5 |
FIGS
FIGS
|
+$5.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MongoDB
MDB
|
+$7M |
| 2 |
Charles River Laboratories
CRL
|
+$6.37M |
| 3 |
Floor & Decor
FND
|
+$5.83M |
| 4 |
Bruker
BRKR
|
+$5.34M |
| 5 |
Asana
ASAN
|
+$5.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.86% |
| 2 | Healthcare | 21.49% |
| 3 | Industrials | 12.78% |
| 4 | Consumer Discretionary | 11.8% |
| 5 | Financials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Viking Therapeutics
VKTX
$3.84B
| $627K | 0.05% |
136,315
+32,372
| +31% | +$181K |
|
|
VMW
477
DELISTED
VMware, Inc
VMW
| $626K | 0.05% |
+5,400
| New | +$710K |
|
|
DCT
478
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $619K | 0.05% |
+20,561
| New | +$662K |
|
479
AeroVironment
AVAV
$7.42B
| $618K | 0.05% |
9,968
-13,832
| -58% | -$1.12M |
|
480
Core & Main
CNM
$8.15B
| $617K | 0.05% |
+20,327
| New | +$557K |
|
481
Celestica
CLS
$40.5B
| $614K | 0.05% |
55,133
+7,033
| +15% | +$72.9K |
|
482
Arcos Dorados Holdings
ARCO
$1.73B
| $613K | 0.05% |
105,220
-4,527
| -4% | -$23K |
|
483
Safety Insurance
SAFT
$1.52B
| $606K | 0.05% |
+7,125
| New | +$572K |
|
|
FFWM
484
DELISTED
First Foundation Inc
FFWM
| $605K | 0.05% |
+24,343
| New | +$649K |
|
485
RBC Bearings
RBC
$17.8B
| $591K | 0.05% |
+2,925
| New | +$628K |
|
486
Kulicke & Soffa
KLIC
$4.62B
| $589K | 0.04% |
+9,733
| New | +$557K |
|
487
Biogen
BIIB
$30.7B
| $587K | 0.04% |
+2,447
| New | +$629K |
|
488
CytomX Therapeutics
CTMX
$714M
| $585K | 0.04% |
135,123
+29,315
| +28% | +$172K |
|
489
Heritage Financial
HFWA
$1.21B
| $585K | 0.04% |
23,923
+4,323
| +22% | +$107K |
|
490
Standard BioTools
LAB
$351M
| $585K | 0.04% |
149,136
+21,236
| +17% | +$99.4K |
|
491
Stevanato
STVN
$5.51B
| $582K | 0.04% |
+25,923
| New | +$615K |
|
492
Heron Therapeutics
HRTX
$94.1M
| $579K | 0.04% |
+63,370
| New | +$647K |
|
493
Kinross Gold
KGC
$28.2B
| $579K | 0.04% |
99,593
+21,493
| +28% | +$129K |
|
494
Live Oak Bancshares
LOB
$1.97B
| $577K | 0.04% |
+6,613
| New | +$551K |
|
495
Palo Alto Networks
PANW
$265B
| $577K | 0.04% |
+6,222
| New | +$538K |
|
496
GCM Grosvenor
GCMG
$751M
| $560K | 0.04% |
53,344
-31,460
| -37% | -$352K |
|
|
BBBY
497
Bed Bath & Beyond
BBBY
$472M
| $558K | 0.04% |
+10,398
| New | +$785K |
|
498
Maravai LifeSciences
MRVI
$996M
| $557K | 0.04% |
13,302
-7,597
| -36% | -$308K |
|
499
Nicolet Bankshares
NIC
$3.57B
| $557K | 0.04% |
6,500
| – | – |
|
500
AMC Global Media
AMCX
$427M
| $555K | 0.04% |
16,104
+8,185
| +103% | +$341K |
|
Similar funds
ISS
GAM
BCM
FACM
TCBWMS
SGI
AAM
RSCM
PDT Partners's Q4 2021 Portfolio in Review
As of Q4 2021, PDT Partners held 1,081 positions worth $1.31B, down 5.7% from $1.39B the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.
PDT Partners withdrew a net $105M in Q4 2021, closing 229 positions and reducing 286 holdings. Its most notable exit was MongoDB, an estimated $7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, PDT Partners opened a new position in Allakos worth $940K.
- PDT Partners's largest Q4 2021 buy was Allakos: 96,046 shares worth $940K.
- PDT Partners added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021, an estimated $5.72M increase.
- PDT Partners's biggest Q4 2021 reduction was Charles River Laboratories, cutting an estimated $6.37M.
- PDT Partners fully exited MongoDB in Q4 2021, selling an estimated $7M.
- PDT Partners's ten largest holdings make up 6.9% of its $1.31B portfolio in Q4 2021.
- PDT Partners opened 330 new positions and closed 229 in Q4 2021.
- PDT Partners's portfolio value fell 5.7% quarter-over-quarter to $1.31B.
Based on PDT Partners's 13F filing for Q4 2021, filed 14 Feb 2022.